{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:19:04Z","timestamp":1785280744583,"version":"3.55.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"\n Importance<\/jats:title>\n Patient-performed teledermoscopy may improve access to dermatologic care, but evidence to guide dermatoscope selection for patient use is limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare a lower-cost, ambient-light, nonpolarized dermatoscope with a higher-cost, illuminated, polarized dermatoscope for patient-performed teledermoscopy following treatment for early-stage melanoma.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This randomized study within a trial was embedded within the MEL-SELF trial and recruited adults previously treated for early-stage melanoma (American Joint Committee on Cancer stages 0-II) in the patient-led surveillance arm of MEL-SELF from specialist and general practitioner-led skin cancer clinics in Australia from December 2021 to June 2024 with 12-month follow-up. Data were analyzed from February 6, 2025, to August 15, 2025.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized (1:1) to receive a polarized (128 [51.0%]) or ambient-light (123 [49.0%]) dermatoscope smartphone attachment. Optional online training was provided. Participants submitted clinician-identified and self-detected lesion images via a secure teledermatology platform at 3-month intervals.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the proportion of participants submitting baseline images of sufficient quality for a teledermatologist to provide a management recommendation. Secondary outcomes included the proportion receiving a management recommendation for at least 1 image during the study period, per-image recommendation proportions, device costs, and qualitative assessments of image quality and usability.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 251 participants (mean [SD] age, 56.0 [11.6] years; 147 female individuals [59%]), 175 (69.7%) received a teledermatologist management recommendation for baseline images (polarized: 92 [71.9%]; ambient light: 83 [67.5%]; difference, 4.4%; 95% CI, \u20137.0% to 15.8%). By 12 months, the proportion receiving at least 1 recommendation was similar between groups (polarized: 104 of 128 [81.3%]; ambient light: 94 of 123 [76.4%]; difference, 4.3%; 95% CI, \u20138.1% to 16.6%). However, a per-image analysis showed more polarized images (913 of 961 [95.0%]) than ambient-light images (706 of 775 [91.1%]) were reportable and supported a recommendation (difference, 3.9%; 95% CI, 1.5% to 6.3%; self-directed lesions: 6.8%; 95% CI, 3.3% to 10.2%). Teledermatologists provided more positive feedback for polarized images; blurriness (n\u2009=\u200914 vs 9) and poor lighting (n\u2009=\u20096 vs 0) were more frequent with ambient-light images. Patient usability ratings were similar (moderately\/very easy: 39.8% vs 36.6%; difference, 3.2%; 95% CI, \u20138.8% to 15.3%), but ambient-light dermatoscope users reported more image quality issues. The polarized device was more expensive ($324.16 vs $35.40).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The results of this study within a trial indicate that both devices enabled patients to perform dermoscopy and receive teledermatology recommendations. The modest image quality advantages of the polarized device must be weighed against its substantially higher cost.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n anzctr.org.au Identifier:\n ACTRN12621000176864<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.4792","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:00:39Z","timestamp":1764777639000},"page":"124","source":"Crossref","is-referenced-by-count":2,"title":["Mobile Dermatoscope Type in Patient-Performed Teledermoscopy"],"prefix":"10.1001","volume":"162","author":[{"given":"Deonna M.","family":"Ackermann","sequence":"first","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Medcalf","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Turner","sequence":"additional","affiliation":[{"name":"Biostatistics Centre, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn K.","family":"Hersch","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Janda","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Guitera","sequence":"additional","affiliation":[{"name":"Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Peter","family":"Soyer","sequence":"additional","affiliation":[{"name":"Frazer Institute, Dermatology Research Centre, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bracken","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Martin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"School of Clinical Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia"},{"name":"The Daffodil Centre, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mar","sequence":"additional","affiliation":[{"name":"Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia"},{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy J. L.","family":"Bell","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"doi250058r1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040.","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi250058r2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","article-title":"Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial.","volume":"158","author":"Ackermann","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi250058r3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/bjd.13550","article-title":"A pilot trial of mobile, patient-performed teledermoscopy.","volume":"172","author":"Manahan","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi250058r4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000506154","article-title":"Is teledermoscopy ready to replace face-to-face examinations for the early detection of skin cancer? consumer views, technology acceptance, and satisfaction with care.","volume":"236","author":"Horsham","year":"2020","journal-title":"Dermatology"},{"issue":"4","key":"doi250058r5","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1404a268","article-title":"Patients\u2019 ability to take dermoscopic follow-up images of atypical melanocytic lesions with smartphones: a pilot study.","volume":"14","author":"Berglund","year":"2024","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"doi250058r6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41746-022-00587-9","article-title":"Dermoscopy practice guidelines for use in telemedicine.","volume":"5","author":"Deda","year":"2022","journal-title":"NPJ Digit Med"},{"issue":"5","key":"doi250058r7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/jamadermatol.2016.6214","article-title":"Proposed technical guidelines for the acquisition of clinical images of skin-related conditions.","volume":"153","author":"Finnane","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi250058r8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archderm.143.3.329","article-title":"Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions.","volume":"143","author":"Benvenuto-Andrade","year":"2007","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi250058r9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13063-021-05231-7","article-title":"Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? a protocol for the MEL-SELF randomised controlled trial.","volume":"22","author":"Ackermann","year":"2021","journal-title":"Trials"},{"issue":"8","key":"doi250058r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007993","article-title":"Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention.","volume":"5","author":"Murchie","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"doi250058r13","doi-asserted-by":"publisher","DOI":"10.2196\/37539","article-title":"The achieving self-directed integrated cancer aftercare intervention for detection of recurrent and second primary melanoma in survivors of melanoma: pilot randomized controlled trial.","volume":"8","author":"Murchie","year":"2022","journal-title":"JMIR Cancer"},{"issue":"1","key":"doi250058r14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13063-024-08004-0","article-title":"Trial forge guidance 4: a guideline for reporting the results of randomised studies within a trial (SWATs).","volume":"25","author":"Arundel","year":"2024","journal-title":"Trials"},{"issue":"5","key":"doi250058r16","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/bjd.18524","article-title":"A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.","volume":"182","author":"Cust","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi250058r17","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8.4.e27","article-title":"eHEALS: the eHealth Literacy Scale.","volume":"8","author":"Norman","year":"2006","journal-title":"J Med Internet Res"},{"issue":"3","key":"doi250058r18","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S2589-7500(20)30001-7","article-title":"Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial.","volume":"2","author":"Janda","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"2","key":"doi250058r19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/jamadermatol.2013.1218","article-title":"Enhanced skin self-examination: a novel approach to skin cancer monitoring and follow-up.","volume":"149","author":"Janda","year":"2013","journal-title":"JAMA Dermatol"},{"key":"doi250058r20","doi-asserted-by":"publisher","DOI":"10.2196\/52400","article-title":"Direct-to-patient mobile teledermoscopy: prospective observational study.","volume":"7","author":"Fan","year":"2024","journal-title":"JMIR Dermatol"},{"issue":"1","key":"doi250058r21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12874-017-0443-0","article-title":"What\u2019s the uptake? pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed.","volume":"17","author":"Bell","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"doi250058r23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/2374373517748657","article-title":"Willingness to pay for teledermoscopy services at a university health center.","volume":"5","author":"Raghu","year":"2018","journal-title":"J Patient Exp"},{"issue":"1","key":"doi250058r24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1357633X15586701","article-title":"Consumer preferences for teledermoscopy screening to detect melanoma early.","volume":"22","author":"Spinks","year":"2016","journal-title":"J Telemed Telecare"},{"issue":"2","key":"doi250058r25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000517257","article-title":"Consumer preference and willingness to pay for direct-to-consumer mobile teledermoscopy services in Australia.","volume":"238","author":"Snoswell","year":"2022","journal-title":"Dermatology"},{"issue":"12","key":"doi250058r26","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/jdv.20376","article-title":"From promise to practice: artificial intelligence in skin cancer screenings.","volume":"38","author":"Li","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi250058r11","volume-title":"Your Guide to Early Melanoma","author":"Melanoma Institute Australia","year":"2021"},{"key":"doi250058r10","unstructured":"Ackermann? D, Drabarek? D, Hersch? J, . SWAT 174: comparing health technologies for participant adherence and trial outcome data collection. Accessed April 4, 2025. https:\/\/www.qub.ac.uk\/sites\/TheNorthernIrelandNetworkforTrialsMethodologyResearch\/FileStore\/Filetoupload,1425893,en.pdf"},{"key":"doi250058r15","unstructured":"R Core Team. R: A language and environment for statistical computing. Accessed April 8, 2025. https:\/\/www.R-project.org\/"},{"key":"doi250058r22","unstructured":"Commonwealth of Australia. 2024 Regional telecommunications review. Accessed August 18, 2025. https:\/\/www.infrastructure.gov.au\/sites\/default\/files\/documents\/2024-regional-telecommunications-review.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2841807\/jamadermatology_ackermann_2025_oi_250058_1770869592.47528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:00:28Z","timestamp":1771430428000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2841807"}},"subtitle":["A Study Within A Trial"],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.4792","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}